Toward Planning Target Volume Margin Reduction for the Prostate Using Intrafraction Motion Correction with Online KV Imaging and Automatic Detection of Implanted Gold Seeds
Overview
Authors
Affiliations
Purpose: The imaging application Auto Beam Hold (ABH) allows for the online analysis of 2-dimensional kV images acquired during treatment. ABH can automatically detect fiducial markers and initiate a beam interrupt. In this study, we investigate the practical use and results of this intrafraction monitoring tool for patients with prostate cancer who have implanted gold seeds treated with a RapidArc technique.
Methods And Materials: A total of 105 patients were included. For setup, the seeds were lined up using 2 orthogonal 2-dimensional kV images. After the setup procedure, ABH was applied at an interval of 3 seconds. The software requires a maximum-allowed deviation to be defined for each seed, which is referred to as a deviation limit (DL). Online, the ABH application evaluates the position of the seeds and indicates for each seed whether or not it exceeds the DL. Patients were divided in 3 groups. For the first group ABH was used with the DL at 6 mm, which corresponds to the planning target volume (PTV) margin. For the second group, the DL was set at 5 mm with an unchanged PTV margin of 6 mm. For the third group, the PTV margin was reduced to 5 mm with a DL of 5 mm. Offline, we performed an analysis of the number of beam stops and resulting re-setups.
Results: ABH initiated a beam interrupt 223 times (13%) during a total of 1736 sessions. By decreasing the DL from 6 mm to 5 mm, the amount of workload for re-setups increased from 6% (group 1) to 14% (groups 2 and 3). Re-setup, 3-dimensional shifts larger than the PTV margin were found in 44%, 35%, and 45% for groups 1,2, and 3, respectively.
Conclusions: Intrafraction imaging of prostate position during treatment using automatic detection of implanted gold seeds was successfully implemented. PTV margins were safely reduced from 6mm to 5mm without a substantial increase in workload.
Dube S, Pareek V, Barthwal M, Antony F, Sasaki D, Rivest R BMC Urol. 2024; 24(1):152.
PMID: 39061006 PMC: 11282858. DOI: 10.1186/s12894-024-01479-8.
Ehret F Strahlenther Onkol. 2024; 200(3):255-258.
PMID: 38182832 PMC: 10876491. DOI: 10.1007/s00066-023-02194-3.
Cetnar A, Degnan M, Pichler J, Jain S, Morelli S, Thomas E Phys Imaging Radiat Oncol. 2023; 25:100422.
PMID: 36875327 PMC: 9978845. DOI: 10.1016/j.phro.2023.100422.
Tetar S, Bruynzeel A, Verweij L, Bohoudi O, Slotman B, Rosario T Phys Imaging Radiat Oncol. 2022; 23:92-96.
PMID: 35844255 PMC: 9283928. DOI: 10.1016/j.phro.2022.06.013.
Kensen C, Janssen T, Betgen A, Wiersema L, Peters F, Remeijer P Radiat Oncol. 2022; 17(1):110.
PMID: 35729587 PMC: 9215022. DOI: 10.1186/s13014-022-02079-2.